Skip to main content

Socio-economic legacy: GetReal's real-world resonance

data by pixabay
IMI project GetReal and its follow-up, GetReal Initiative, show new methods of RWE collection and synthesis could be adopted earlier in pharmaceutical R&D and the healthcare decision making process Image by pixabay , public domain

 

In October 2013, IMI launched GetReal, a three-year project made up of a consortium of pharma companies, academia, HTA agencies and regulators, patient organisations and SMEs. GetReal aimed to show how robust new methods of real-world evidence (RWE) collection and synthesis could be adopted earlier in pharmaceutical R&D and the healthcare decision making process.

They developed a suite of tools that are helping research teams use alternative evidence generating strategies to deliver more focused research in pharmaceutical R&D, and allow healthcare decision makers to be more certain when providing patients with access to new treatments.

In June 2018 the follow up project 'GetReal Initiative' was launched, carrying on the legacy of the initial project by promoting the uptake of their valuable tools, methodologies, best practices and policy recommendations. 

Read about the mark they left on the drug development process in this thread: 

 

Read more

The GetReal Initiative 

The socio-economic impact of IMI projects

Socio-economic legacy: the European Lead Factory

Socio-economic legacy: EHR4CR's data reuse revolution

16/04/2020

Related projects: 

Manage your newsletter subscriptions
Stay informed - subscribe to our newsletter.